“For the year to 10/26 BRK bought back 0.85% of its shares and since repos began in 2018 spent $63.7 billion repurchasing 11% of the shares outstanding at an average price of $353,952 per share [$236/b], a terrific use of capital buying shares at wide discounts to intrinsic value.”
Why in the world anyone follows Bloomstran and his use of Berkshire/Buffett to sell his fees is beyond me. The guys is simply selling, selling, and selling.
He does a good job summarizing the financials. He gets it right when the news articles (and some here) get it wrong, e.g. the “20% increase in profits”.
His IV estimates are very optimistic, bordering on fan-fiction.
Read it. You called his out. I want to compare it to yours. If the above is an “analysis” then you should begin your next analysis of a business with a dictionary.
True. But there is a difference between simplicity and complete absence, which you only have demonstrated the latter. I’m comfortable you haven’t done any. I’ll move on now.
jk
Bloomstran makes a model out of criticizing ARK and Cathie Wood. I can’t help but wonder what the hell that’s all about. I think she is autistic and (not relatead to being autistic) also whacko. But is this his job?
Bloomstran needed a cult and he’s successful apparently with his use of Buffett. Is he really a great business analyst? Don’t make me laugh so much I throw up please.
The guy is just another…one of the endless Tilson types looking to sell something and looking for those who will latch on for dear life and never let go.
Here are some posters’ comments about Bloomstran’s intrinsic value estimates for Berkshire:
DetroitBadBoy: “fantastical,” “wrong”
AdrianC: “very optimistic, bordering on fan-fiction”
Let’s take a look at the data. In each year back to 2015, Bloomstran has published conservative intrinsic value estimates in his annual letters, using multiple methodologies. He publishes his letters before Berkshire releases its annual results, so his IV estimates are based on his estimate of Berkshire’s annual financial results for the year-end preceding his letters’ publication date.
Of the valuation methods used, he prefers the “Sum of the Parts” and the “GAAP Adjusted Financials” methods. In column 3 below, I used the higher of his two preferred IV estimates. In column 4 below, I used Yahoo! Finance historical stock quotes.
1. Semper Augustus Letter Publication Date
2. Based on Estimated Business Results as of
3. Higher of Two Preferred IV Estimates per “A” Share
4. First Date “A” Shares Closed at or Greater Than IV Estimate
5. Duration Between Publication Date and Price Realization, in Months (column 4 minus column 1)
02/01/2016
12/31/2015
$295,134
12/04/2017
22
02/12/2017
12/31/2016
$314,534
01/12/2018
11
02/11/2018
12/31/2017
$383,049
03/08/2021
37
02/14/2019
12/31/2018
$406,754
04/16/2021
26
02/14/2020
12/31/2019
$462,090
01/04/2022
23
02/15/2021
12/31/2020
$522,556
03/21/2022
13
02/22/2022
12/31/2021
$603,882
N/A
???
It’s been less than 9 months since his most recent IV estimate, and I’ll grant you, the stock price is currently well short of that estimate. I’d note that many stocks, including Berkshire, are down in recent months. But for the remaining six IV estimates, for which the stock price has always eventually met or exceeded his estimate, it has taken only an average of 22 months for that to occur.
Value Investors Club founder Joel Greenblatt has said, “I actually have taught at Columbia for 23 years and I make a promise to my students first day of class. I promise them if they do good valuation work the market will agree with them. I just never tell them when. Could be a couple of weeks, could be two or three years. But that is the secret. To have a steady disciplined process to value companies and to be confident enough to stick with it when it’s not working in the short term. The market is very emotional in the short term.”
I disagree with the above posters’ characterizations, and I’m quite happy to take Bloomstran’s Berkshire IV estimates and sit on my arse for a couple of years, if that’s all it takes. Life is rarely that easy.
Agree. I have seen no one more thoughtful wrt Berkshire which he has been following closely since 1999. His annual letter is incredibly thorough and entertaining and his GAAP adjusted earnings approach and valuation methodologies are very thoughtful and reasonable imo.
I really appreciate his selflessness in sharing his comprehensive Semper annual letter. Chris gave a nice talk at the Gabelli conference in Omaha and I chatted with him briefly after the Markel brunch conference at the Marriott. He was most gracious, genuine and entertaining. There was no evidence of self-promotion. His and Markel’s approach to investing certainly resonates with that audience.
What do you do with his IV estimate? Sell when it is reached?
I think perhaps we’re approaching from opposite ends? I use my own IV estimates to attempt to get good value when I buy.
One other thing, I did read his last letter. I’m not going to go back and get the quote, but I’m pretty sure in one IV estimate he included earnings on cash that he expects to be invested soon. Not interest on the cash, but actual business earnings. That’s the fan-fiction.